4 citations
,
October 2021 in “Journal of The European Academy of Dermatology and Venereology” Low-dose oral minoxidil increases hair density and thickness in people with hair loss.
1 citations
,
May 2021 in “Dermatology practical & conceptual” This study found that iontophoresis combined with growth factors improved hair density and reduced hair loss in patients with androgenetic alopecia and telogen effluvium, with no serious side effects reported.
November 2020 in “Journal of The American Academy of Dermatology” This case report highlights that patients with long-standing alopecia areata treated with oral JAK inhibitors experienced unexpected hair regrowth patterns resembling male-pattern baldness.
August 2020 in “Rossiiskii Zhurnal Kozhnykh i Venericheskikh Boleznei” This review analyzes platelet-rich plasma preparation methods for treating androgenetic alopecia but reports no new clinical results, suggesting a need for further research to evaluate efficacy and tolerance.
7 citations
,
April 2020 in “Dermatologic Therapy” In this study, nine male cases of androgenetic alopecia showed marked improvement after receiving systemic dexpanthenol treatment.
8 citations
,
January 2020 in “Journal of Cutaneous Medicine and Surgery” Oral minoxidil may improve hair loss in men and women, but has some side effects.
January 2018 in “Sohag Medical Journal” September 2017 in “Asian Pacific journal of health sciences”
4 citations
,
June 2017 in “Pharmaceutical and Biological Evaluations” This review examines current and emerging treatments for androgenetic alopecia and alopecia areata, noting no new results, and highlights promising approaches like novel drug combinations and gene therapy.
7 citations
,
March 2017 in “Actas Dermo-Sifiliográficas” This review summarizes recent therapeutic advancements in treating various forms of alopecia, including new applications of oral minoxidil, dutasteride, finasteride, Janus kinase inhibitors, and novel hair transplant techniques, without presenting original research results.
This study found that combining platelet-rich plasma injections with minoxidil in treating androgenetic alopecia increased the number of hair follicles, anagen phase hairs, and decreased telogen phase hairs compared to minoxidil alone.
January 2017 in “프로그램북(구 초록집)”
January 2014 in “Anales Médicos de la Asociación Médica del Centro Médico ABC” This study suggests that a combination of topical minoxidil with oral finasteride or dutasteride promotes hair growth in treating androgenetic alopecia, with only minor safety concerns reported.
165 citations
,
August 2013 in “Lasers in Surgery and Medicine” This review discusses the potential mechanisms and evidence supporting low-level laser therapy for stimulating hair growth in men and women, while noting its safety and effectiveness but needing further study on specific parameters.
January 2012 in “Journal of Practical Dermatology” This review discusses various treatments for androgenetic alopecia in both men and women and reports no new clinical results; the authors note the importance of understanding therapeutic mechanisms, dosages, and adverse reactions.
This document is informational and does not present new research findings, and it advises consulting personal healthcare providers for medical recommendations.
72 citations
,
January 2001 in “Drugs” This review discusses current and emerging drug therapies for treating androgenetic alopecia and alopecia areata, and reports no clinical results; it highlights a need for improved and novel treatments.
2 citations
,
September 1997 in “Journal of The European Academy of Dermatology and Venereology” Topical spironolactone effectively treats hair loss in women.
4 citations
,
March 1988 in “PubMed”